Nano-X Imaging Ltd. (NASDAQ: NNOX), a company focused on transforming global healthcare through accessible medical imaging, has announced a securities purchase agreement with a single long-term institutional investor for a registered direct offering. The offering is expected to generate approximately $8 million in gross proceeds before fees and expenses, providing the company with additional capital to advance its strategic initiatives.
Under the terms of the agreement, Nano-X will sell 8 million ordinary shares, or prefunded warrants in lieu thereof, along with warrants to purchase up to an additional 8 million ordinary shares. The combined purchase price is set at $1.00 per share and accompanying warrant. The warrants will have an exercise price of $1.15 per share, become exercisable six months after issuance, and expire five years after the closing date. The offering is anticipated to close on or about Aug. 7, 2026, subject to customary closing conditions.
Nano-X stated that it intends to use the net proceeds from the offering for working capital and general corporate purposes. This capital infusion is expected to support the continued development and commercialization of its integrated medical imaging and healthcare services platform, which includes the Nanox.ARC system, AI-based analytics, cloud-based software, and teleradiology services.
The announcement comes at a time when the company is actively working to expand the reach of medical imaging beyond traditional hospital settings. By leveraging proprietary digital X-ray technology and AI-driven analytics, Nano-X aims to enhance routine imaging workflows, support early disease detection, and improve patient outcomes. The company's ecosystem is designed to lower barriers to adoption and improve utilization of imaging services, particularly in underserved regions.
A.G.P./Alliance Global Partners is serving as the sole placement agent for the transaction. The offering is part of Nano-X's broader strategy to secure funding that will enable it to scale its operations and bring its innovative solutions to a wider market. The company has previously emphasized its commitment to preventive healthcare, and this financing round is expected to further those efforts.
Investors and industry observers will be watching to see how Nano-X deploys these funds to accelerate its growth trajectory. The company's focus on integrating imaging technology, AI, cloud infrastructure, and health IT solutions positions it as a potential disruptor in the medical imaging space. With the additional capital, Nano-X can continue to invest in research and development, expand its commercial footprint, and pursue partnerships that align with its mission of advancing preventive care worldwide.
For more details on the offering, the full press release is available at https://ibn.fm/5fNi8. Additional information about Nano-X and its products can be found on the company's website at https://www.nanox.vision/.
